Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Izurieta, Hector S."'
Recombinant Zoster Vaccine (Shingrix): Real-World Effectiveness in the First 2 Years Post-Licensure.
Autor:
Izurieta HS; Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA., Wu X; Acumen LLC, Burlingame, California, USA., Forshee R; Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA., Lu Y; Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA., Sung HM; Acumen LLC, Burlingame, California, USA., Agger PE; Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA., Chillarige Y; Acumen LLC, Burlingame, California, USA., Link-Gelles R; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Lufkin B; Acumen LLC, Burlingame, California, USA., Wernecke M; Acumen LLC, Burlingame, California, USA., MaCurdy TE; Acumen LLC, Burlingame, California, USA.; Centers for Medicare & Medicaid Services, Washington, DC, USA., Kelman J; Centers for Medicare & Medicaid Services, Washington, DC, USA., Dooling K; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.; Department of Economics, Stanford University, Stanford, California, USA.
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2021 Sep 15; Vol. 73 (6), pp. 941-948.
Autor:
Izurieta HS; Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland., Wu X; Acumen LLC, Burlingame, California., Lu Y; Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland., Chillarige Y; Acumen LLC, Burlingame, California., Wernecke M; Acumen LLC, Burlingame, California., Lindaas A; Acumen LLC, Burlingame, California., Pratt D; Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland., MaCurdy TE; Acumen LLC, Burlingame, California.; Department of Economics, Stanford University, Stanford, California., Chu S; Centers for Medicare and Medicaid Services, Washington, District of Columbia., Kelman J; Centers for Medicare and Medicaid Services, Washington, District of Columbia., Forshee R; Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland.
Publikováno v:
Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2019 Jul; Vol. 28 (7), pp. 993-1001. Date of Electronic Publication: 2019 Jun 05.
Autor:
Izurieta HS; Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA.; Universidad Rey Juan Carlos, Madrid, Spain., Wernecke M; Acumen LLC, Burlingame, California, USA., Kelman J; Centers for Medicare and Medicaid Services, Washington, DC, USA., Wong S; Acumen LLC, Burlingame, California, USA., Forshee R; Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA., Pratt D; Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA., Lu Y; Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA., Sun Q; Acumen LLC, Burlingame, California, USA., Jankosky C; Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA., Krause P; Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA., Worrall C; Centers for Medicare and Medicaid Services, Washington, DC, USA., MaCurdy T; Acumen LLC, Burlingame, California, USA., Harpaz R; National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2017 Mar 15; Vol. 64 (6), pp. 785-793.